MNPR R&D Expenses

Monopar Therapeutics Inc · R&D Expenses

MNPR logo

MNPR R&D Expenses

Latest reported$14.78M
MNPR TTM R&D Expenses ($280.36K → $14.78M)
High-resolution chart · PNG

MNPR r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monopar Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
14,784,929
11,748,097
9,904,225
15,887,744
14,282,273
13,683,251
13,005,986
4,116,957
4,449,199
4,912,934
5,600,193
6,667,570
7,083,280
7,567,038
7,591,601
7,471,310
7,566,402
6,964,361
6,493,208
6,142,904
5,571,498
4,927,571
4,065,199
3,016,604
1,980,534
1,477,325
1,968,518
1,905,722
1,989,560
2,152,913
1,774,454
1,562,787
15,941,103
15,760,049
15,436,644
15,224,657
611,857
357,177
280,355
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.